Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

A staff from checks the vaccine before administering it. Photograph by Albert Masias
Press release
Press release |
21 June 2021
COVID-19
South Africa

MSF responds to news of first mRNA COVID vaccine technology transfer hub being set up in South Africa

2 min
"" Photograph by Tadeu Andre
Press release
Press release |
15 June 2021
Tuberculosis

MSF: Governments off track on providing tools to prevent TB, the second biggest infectious disease killer after COVID-19

6 min
MSF International President, Dr. Christos Christou, visited our COVID-19 emergency projects in Rondônia, Brazil. Photograph by Diego Baravelli
Press release
Press release |
10 June 2021
COVID-19

MSF statement on G7 summit discussions on pandemic response

7 min
View of the banner deployed by MSF in front of the World Trade Organization (WTO) in Geneva calling on certain governments to stop blocking the landmark waiver proposal on intellectual property (IP) during the pandemic. Photograph by Pierre-Yves Bernard
Press release
Press release |
10 June 2021
COVID-19

MSF response to the European Parliament’s resolution supporting the ‘TRIPS waiver’

3 min
MSF COVID-19 emergency projects in Rondônia, Brazil. Photograph by Diego Baravelli
Press release
Press release |
07 June 2021
COVID-19

EU, UK, Switzerland, Norway must stop blocking negotiations on landmark pandemic monopoly waiver

6 min
Bonifácia de Oliveira, 109-years-old, was a COVID-19 patient that left a mark on everyone at Tefé Regional Hospital due to her determination and physical and emotional stability. She worked all her life in agriculture and became literate at the age of 100. Photograph by Mariana Abdalla
Press release
Press release |
04 June 2021
COVID-19

MSF: US global COVID-19 vaccine distribution plan is not enough

3 min
MSF’s Health Educator distributing soaps to a street- hawker in M-East Ward, Mumbai. Photograph by Premananda Hessenkamp
Press release
Press release |
21 May 2021
COVID-19

MSF responds to revised proposal on TRIPS waiver submitted to WTO by sponsoring governments

3 min
""
Press release
Press release |
17 May 2021
COVID-19

MSF: US must commit to sharing more surplus COVID-19 vaccine doses

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury